934172-61-9

Basic information

• Product Name: 1H-pyrazole-1-acetic acid, 3-methyl-, ethyl ester
• Synonyms: 1H-pyrazole-1-acetic acid, 3-methyl-, ethyl ester;ethyl (3-methyl-1H-pyrazol-1-yl)acetate;2-(3-methyl-1-pyrazolyl)acetic acid ethyl ester;2-(3-methylpyrazol-1-yl)acetic acid ethyl ester;ethyl 2-(3-methylpyrazol-1-yl)acetate;ethyl 2-(3-methylpyrazol-1-yl)ethanoate;SBB000021;ZINC02565682
• CAS NO: 934172-61-9
• Molecular Formula: C₈H₁₂N₂O₂
• Molecular Weight: 168.2
• Mol File: 934172-61-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-pyrazole-1-acetic acid, 3-methyl-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-pyrazole-1-acetic acid, 3-methyl-, ethyl ester(934172-61-9)
• EPA Substance Registry System: 1H-pyrazole-1-acetic acid, 3-methyl-, ethyl ester(934172-61-9)

Safety Data

• Hazardous Substances Data: 934172-61-9(Hazardous Substances Data)

Usage

Structure

1H-pyrazole-1-acetic acid derivative with an ester group attached to the ethyl group

Ester

Ethyl ester of 1H-pyrazole-1-acetic acid

Usage

Scientific research, particularly in the field of organic chemistry, and possible industrial applications

Hazards

Flammable, harmful if ingested, inhaled, or absorbed through the skin

Environmental implications

Should be disposed of according to local regulations and guidelines.

Upstream product

• 1453-58-3 3-Methylpyrazole 
• 105-39-5 chloroacetic acid ethyl ester 
• 180741-30-4 (3-methyl-1H-pyrazol-1-yl)acetic acid 
• 64-17-5 ethanol 
• 105-36-2 ethyl bromoacetate 

Downstream Products

• 1109216-79-6 C₁₅H₁₆Cl₂N₂O₂ 
• 1398326-38-9 7-chloro-6-(4-(dimethylamino)phenyl)-4-hydroxy-3-(3-methyl-1H-pyrazol-1-yl)quinolin-2(1H)-one 

Relevant articles and documents

Aqueous N-methylmorpholine N-oxide as a new medium for alkylation of pyrazoles

[Figure not available: see fulltext.] It is shown that alkylation of pyrazoles with (E)/(Z)-1,3-dichlorobut-2-enes can be carried out in an alkaline aqueous medium in the presence of N-methylmorpholine N-oxide. In some cases, this technique may substitute

4-(Benzoimidazol-2-yl)-thiazole Compounds and Related Aza Derivatives

The invention relates to compounds of Formula (I) wherein ring A, X, (R1)n, R2, R3, R4, R4′, R5, n, and p are as described in the description; to pharmaceutically acceptable salts thereof, and to the use of such compounds as medicaments, especially as modulators of the CXCR3 receptor.

Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators

The present invention relates to substituted aryl or heteroarylpiperidine derivatives of structure (I) as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention.